Marinus Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript
So thanks, everybody, for joining us. I'm Brian Abrahams, one of the senior biotech analysts here at RBC Capital Markets. Our next featured company is Marinus Pharmaceuticals. From Marinus, we have their Chief Scientific Officer, Alex Aimetti, and their Chief Financial Officer, Steve Pfanstiel. Alex and Steve, thanks so much for joining us.
Yeah, thanks for having us.
Yeah, morning. Thanks for having us.
Questions & Answers
Great. So, there's a lot to cover. So, let's kick things off. Maybe starting -- we'll start on the commercial side of things. Aimetti, tell me -- can you talk to us -- you just reported good sales and continued growth of the drug.
Tell us how the launch is progressing now with two full quarters of sales
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
